OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Recalling firm: Hall Global, LLC
Why it was recalled
Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
The exact product
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
10097902, 10186904, 10235905, and 10278906
Recall details
- Recall number
- F-0070-2020
- Event ID
- 83891
- FDA status
- Terminated
- Initiated
- Sep 25, 2019
- Reported
- Oct 30, 2019
- Classified
- Oct 24, 2019
- Terminated
- Feb 20, 2020
- Quantity
- 1007 packages of 5 count caps
- Location
- Southlake, TX, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Contract Manufacturer sends products to distribution centers owned by clients or direct to client company for distribution via internet to end product user.
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.